Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005;112:e154–235.
MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure. Lancet 1999;353:2001–7.
Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303–10.
Pitt B, Zannad F, Remme WJ, et al for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709–717.
Reicin G, Miksic M, Yik A, Roman D. Hospital Supplies and Medical Technology 4Q05 Statistical Handbook: Growth Moderating But Outlook Remains Strong. New York: Morgan Stanley Equity Research North America; 2005:44.
Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. Circulation 2002;106:2145–61.
Abraham WT, Fisher WG, Smith AL, Delurigic DB, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.
Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. JAMA 2003;289:2685–94.
Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873–80.
Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026–33.
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med 2004;350:2140–50.
Cleland JGF, Daubert JC, Erdmann E, et al., for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352: 1539–49.
Saxon LA, DeMarco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization of echocardiographic measures of remodeling. Circulation 2002;105:1304–10.
Leclercq C, Kass DA. Retiming the failing heart: principle and clinical status of cardiac resyncrhonization. J Am Coll Cardiol 2002;39:194–201.
Mehra MR, Greenberg BH. Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol 2004;43:1145–8.
Kass DA, Chan CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99;1567–73.
Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825–31.
Packer M, Coats AJ, Fowler MB, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651–8.
CIBIS-II Investigators and committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). Lancet 1999;353:9–13.
Wikstrand J, Hjalmarson A, Waagstein F, et al. MERIT-HF Study Group. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure. J Am Coll Cardiol 2002;40:491–8.
Gasparini M, Mantica M, Galimberti P, et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 2003;26:175–80.
Aranda JM Jr, Woo GW, Conti JB, Schofield RS, Conti CR, Hill JA. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. Am J Cardiol 2005;95:889–91.
Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37.
Aranda JM Jr., Woo GW, Schofield RS, et al. Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function. J Am Coll Cardiol 2005;46:2193–8.
Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258–63.
Breithardt OA, Sinha AM, Schwammenthal, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765–70.
St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985–90.
Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993–3001.
Van Gelder BM, Bracke FA, Meijer A, et al. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 2004;93:1500–1503.
Leon AR, Abraham WT, Brozena S, et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate to severe heart failure. J Am Coll Cardiol 2005;46:2298–304.
Bordachar P, Lafitte S, Reuter S, et al. Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. J Am Coll Cardiol 2004;44:2157–65.
Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004:441834–40.
Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615–22.
Adamson PB, Abraham WT, Love C, Reynolds D. The evolving challenge of chronic heart failure management: A call for a new curriculum for training heart failure specialists. J Am Coll Cardiol 2004;44:1354–7.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Aranda, J.M. (2008). Recurrent Heart Failure and Appropriate Evaluation After Cardiac Resynchronization Therapy. In: Barold, S.S., Ritter, P. (eds) Devices for Cardiac Resynchronization. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71167-6_26
Download citation
DOI: https://doi.org/10.1007/978-0-387-71167-6_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-71166-9
Online ISBN: 978-0-387-71167-6
eBook Packages: MedicineMedicine (R0)